CTOs on the Move

Polyfoam Corp

www.polyfoamcorp.com

 
Polyfoam Corp is a Northbridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Consulmed

Consulmed LLC is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Consulmed LLC is based in Bountiful, UT. You can find more information on Consulmed LLC at www.consulmed.com

Ice Biotech

Ice Biotech, Inc. is a Dundas, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

INVIVO

Locally-owned, INVIVO Wellness specializes in an integrated and whole-person approach to wellness and self-care healing. We are experts in the fields of physical therapy, massage therapy, chiropractic, yoga therapy, mental wellness, personal training a...

Speciality Medical Billing

Speciality Medical Billing is a Templeton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.